Liu et al. [10] found that TBL1XR1 overexpression provoked lymphangiogenesis and lymphatic metastasis in ESCC and may represent a novel prognostic biomarker and therapeutic target. Here, TBL1XR1 is linked to esophageal squamous cell carcinoma.